Home Vectura

Vectura

acquired
IPO
Drug Delivery Product Developer
Basic
Enterprise Profile

Basic Information

Vectura is a provider of innovative inhaled drug delivery services, enabling partners to bring their medicines to patients. With distinctive proprietary technology and drug development expertise, Vectura is one of the few global companies with the devices, formulations, and development capabilities to deliver a wide range of complex inhaled therapies. Vectura has 13 major inhaled products and 11 non-inhaled products, which are sold by partners generating global royalty revenues, and has a portfolio of partnered drugs in clinical development.
Vectura Group Ltd
England,United Kingdom
101~500 people
January 01, 1997
info@vectura.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Manufacturing of Medical Equipment, Instruments, and Consumables
Concept
Therapeutic Products
Application Scenarios
Medical Device Consumables